Kodiak Sciences Inc. (KOD) - Long-Term Debt to Capital

Kodiak Sciences Inc. (KOD) specializes in the development of ophthalmological treatments. The asset's price trajectory reflects the current indicator 2.35. The company's financial stability is subject to risks due to a lack of revenue and the costs associated with testing new products. Future success depends on the approval of its flagship drug. High costs in the late stages of research force the company to regularly seek third-party financing to cover funding deficits.

This ratio compares liabilities with a maturity of over one year to equity, making it possible to identify hidden financial instability or balance sheet manipulation. By analyzing the long-term debt load chart, an investor can assess how resilient the capital of Kodiak Sciences Inc. (KOD) is in supporting the development of unique biopolymers, which provide significant pricing power by radically reducing injection frequency.